Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for arthritis.

Tetsuya Tomita1, Hideo Hashimoto, Hideki Yoshikawa

  • 1Falk Cardiovascular Research Center, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA. tomita@ort.med.osaka-u.ac.jp

Current Drug Targets
|October 28, 2003
PubMed
Summary

Gene therapy offers new hope for arthritis treatment, with clinical trials underway for rheumatoid arthritis using interleukin-1 receptor antagonist gene transfer. Future research focuses on safer, non-viral gene delivery systems and novel DNA technologies for enhanced therapeutic effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tailored therapeutic strategies for synovial sarcoma: receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001.

Cancer letters·2014
Same author

Bone substitutes and implantation depths for subchondral bone repair in osteochondral defects of porcine knee joints.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2014
Same author

Celecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis.

International journal of rheumatic diseases·2014
Same author

Extraneural metastasis of ependymoma in the cauda equina.

Global spine journal·2014
Same author

Osteochondral tissue engineering with biphasic scaffold: current strategies and techniques.

Tissue engineering. Part B, Reviews·2014
Same author

In vivo movement of femoral flexion axis of a single-radius total knee arthroplasty.

The Journal of arthroplasty·2014

Area of Science:

  • Molecular biology
  • Gene therapy
  • Immunology

Background:

  • Arthritis treatment is evolving with advancements in molecular biology.
  • Gene transfer methods are being explored for managing arthritis, including rheumatoid arthritis.
  • Current clinical trials utilize retrovirus-mediated delivery of interleukin-1 receptor antagonist genes.

Purpose of the Study:

  • To review the current state and future directions of gene transfer for arthritis.
  • To highlight the challenges and potential of gene delivery systems and therapeutic gene selection.
  • To explore novel DNA technologies like antisense oligonucleotides for arthritis therapy.

Main Methods:

  • Review of existing clinical trials and research in gene therapy for arthritis.
  • Discussion of viral-mediated gene delivery systems and the need for non-viral alternatives.

Related Experiment Videos

  • Exploration of DNA technologies, including antisense oligonucleotide (ODN) strategies and decoy ODN for nuclear factor-kappaB (NF-κB) binding sites.

    • Main Results:

    • Clinical trials for rheumatoid arthritis using ex vivo gene transfer are ongoing.
    • Non-viral gene transfer systems are needed for improved safety and efficiency.
    • Antisense oligonucleotide (ODN) strategies and decoy ODN show promise in regulating disease-related gene expression.

    Conclusions:

    • Gene therapy holds significant potential for arthritis treatment.
    • Development of efficient and safe non-viral gene delivery systems is crucial.
    • Targeting transcriptional factors with DNA technologies offers a promising therapeutic approach for arthritis.